3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
3
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gynecologic
1
Conditions
Neoplasms
3
Skin Diseases
2
Neoplasms by Site
2
Carcinoma, Renal Cell
2
Uveal Melanoma
1
Uterine Neoplasms
1
Uterine Diseases
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Uterine Cervical Diseases
1
Urogenital Neoplasms
1
Urogenital Diseases
1
Prostatic Neoplasms
1
Precancerous Conditions
1
Neoplasm Metastasis
1
Kidney Neoplasms
1
Hematologic Diseases
1
Genital Neoplasms, Female
1
Genital Diseases, Female
1
Genital Diseases
1
Female Urogenital Diseases and Pregnancy Complications
1
Communicable Diseases
1
Breast Neoplasms
1
Breast Diseases
1
Autoimmune Diseases
1
Interventions
GX-188 vaccine
4
human papillomavirus vaccine, L1 type 16, 18
3
Human Papillomavirus DNA Tests
3
Colposcopy
3
Blood Specimen Collection
3
Vaccines
2
VGX-3100
2
Topotecan
2
Restraint, Physical
2
Paclitaxel
2
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
2
Cisplatin
2
Biopsy
2
5-aminolevulinic acid hexyl ester
2
4,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone
2
terameprocol
1
poly(gamma-glutamic acid)
1
poly ICLC
1
methyl 5-aminolevulinate
1
epigallocatechin gallate
1
artesunic acid
1
artemisinin
1
ZYC101a
1
Watchful Waiting
1
Vaccines, Synthetic
1
Transurethral Resection of Prostate
1
Pregnancy Tests
1
Pemetrexed
1
Papillomavirus Vaccines
1
Ointments
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Uterine Cervical Dysplasia
×
Watchful Waiting
×
Clear all
NCT06815939
2026-01-29
OPTICS
DL Analytics
Phase NA
Recruiting
10,000 enrolled